Recombinant Antibodies in Cancer Therapy

Author(s): M. S. Nayeem, Rizwan H. Khan

Journal Name: Current Protein & Peptide Science

Volume 7 , Issue 2 , 2006

Become EABM
Become Reviewer
Call for Editor


The application of recombinant immunotoxin and radioimmunoconjugate in Cancer therapy has revived the "magic bullet" concept predicted a century ago. Many of the recombinant antibodies have received FDA approval for various indication of cancer in recent years and numerous others are in clinical trials.

Keywords: Cancer therapy, recombinant immunotoxins, radioimmunoconjugates, engineered antibody, recombinant antibody

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2006
Page: [165 - 170]
Pages: 6
DOI: 10.2174/138920306776359768
Price: $65

Article Metrics

PDF: 2